China
· Delayed Price · Currency is CNY Wanbangde Pharmaceutical Holding Group Company Description
Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine, chemical raw materials, and chemical preparations in China and internationally.
The company operates through Pharmaceutical Production and Sales, and Medical Equipment and Personal Equipment Production and Sale segments.
It offers drugs products used to treat cardiovascular and cerebrovascular diseases; and nervous, respiratory, mental, and digestive system diseases.
The company also develops and sells medical devices, including orthopedic implant devices comprised of thoracolumbar fusion, cervical fusion, spinal internal fixation systems, independent fusion devices, unicompartmental knee joints, etc.; medical equipment; disposable sterile medical polymer consumables; and protective equipment.
In addition, it provides hospital engineering services. The company was formerly known as Wanbangde New Building Materials Co., Ltd. and changed its name to Wanbangde Pharmaceutical Holding Group Co., Ltd. in April 2020.
Wanbangde Pharmaceutical Holding Group Co., Ltd. was founded in 1985 and is headquartered in Taizhou City, China.
| Country | China |
| Founded | 1985 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,605 |
| CEO | Shouming Zhao |
Contact Details
Address: No. 28, Baizhang North Road Taizhou City, Zhejiang Province 317500 China | |
| Phone | 86 57 6861 83999 |
| Website | wepon.com.cn |
Stock Details
| Ticker Symbol | 002082 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000001P94 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Shouming Zhao | GM and Chairman of the Board |
| Wang Tianfang | Financial Director and Non-Independent Director |
| Tongke Liu | Deputy GM, Secretary of the Board of Directors and Director |